Honeysuckle‐Derived Nanovesicles Regulate Gut Microbiota for the Treatment of Inflammatory Bowel Disease
Advanced Science · 2025-12 · 12 (45)
DOI: 10.1002/advs.202505208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.09.2025. Verfasst von Yuanyuan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Rehabilitation Medicine, Rehabilitation and Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Inflammatory Bowel Diseases, Lonicera. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease, significantly impairs patients’ quality of life and is characterized by a compromised intestinal barrier, pathogenic bacterial colonization, and chronic inflammation. The gut microbiota has emerged as a therapeutic target for IBD owing to its role in modulating immune responses, metabolic pathways, and barrier function. In this study, the therapeutic potential of honeysuckle‐derived nanovesicles (HNVs) in a dextran sodium sulfate‐induced murine model of UC is investigated. Oral administration of HNVs alleviates colitis symptoms, reduces colonic inflammation and histopathological damage, restores Treg/Th17 balance, and repairs intestinal barrier integrity. These effects are associated with favorable alterations in the gut microbiota, including an increase in beneficial bacteria and a decrease in pathogenic species, along with elevated levels of short‐chain fatty acids (SCFAs), which are essential for maintaining mucosal immunity and barrier function. Moreover, metabolomic analysis reveals that HNVs promoted bile acid (BA) absorption and regulated BA metabolism, contributing to the maintenance of intestinal immune homeostasis. Collectively, these findings demonstrate the protective effects of HNVs through modulation of SCFA levels and BA metabolism, supporting their potential as a promising therapeutic strategy for the treatment of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Rehabilitation Medicine, Rehabilitation and Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Clinical Research Institute, Zhejiang Provincial People's Hospital,…
- Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Bionanomaterials & Translational Engineering…
- Department of Critical Care, Shanghai Cancer Center, Fudan University, Shanghai, 200032, China.
ORCID-Profile: Huiyu Liu
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Wang, Y., Zhou, Y., Wu, Q., Li, Y., Huang, Y., Yu, K., Li, P., Lv, Z., Liu, H., Zou, H., Liu, H., & Mou, X. (2025). Honeysuckle‐Derived Nanovesicles Regulate Gut Microbiota for the Treatment of Inflammatory Bowel Disease. Advanced Science, 12(45). https://doi.org/10.1002/advs.202505208
Vancouver
Wang Y, Zhou Y, Wu Q, Li Y, Huang Y, Yu K, et al. Honeysuckle‐Derived Nanovesicles Regulate Gut Microbiota for the Treatment of Inflammatory Bowel Disease. Advanced Science. 2025;12(45). doi:10.1002/advs.202505208
BibTeX
@article{Wang2025,
author = {Wang, Yuanyuan and Zhou, Yuanhao and Wu, Qingyuan and Li, Yishu and Huang, Yilin and Yu, Kexin and Li, Ping and Lv, Zhenye and Liu, Haotian and Zou, Hai and Liu, Huiyu and Mou, Xiaozhou},
title = {Honeysuckle‐Derived Nanovesicles Regulate Gut Microbiota for the Treatment of Inflammatory Bowel Disease},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {45},
doi = {10.1002/advs.202505208}
}
EUVIMED